ADVFN Logo ADVFN

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
iTeos Therapeutics Inc

iTeos Therapeutics Inc (ITOS)

8.15
0.25
(3.16%)
Closed January 05 4:00PM
8.15
-0.01
(-0.12%)
After Hours: 6:01PM
Advanced chart
Rendering Error

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
8.15
Bid
7.52
Ask
8.29
Volume
278,018
7.93 Day's Range 8.185
7.09 52 Week Range 18.75
Market Cap
Previous Close
7.90
Open
7.95
Last Trade
71
@
8.15
Last Trade Time
Financial Volume
$ 2,251,226
VWAP
8.0974
Average Volume (3m)
573,435
Shares Outstanding
36,533,918
Dividend Yield
-
PE Ratio
-2.65
Earnings Per Share (EPS)
-3.08
Revenue
12.6M
Net Profit
-112.64M

About iTeos Therapeutics Inc

ITeos Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of immuno-oncology therapeutics for patients. Its product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist and EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoin... ITeos Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of immuno-oncology therapeutics for patients. Its product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist and EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody. Show more

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Headquarters
Wilmington, Delaware, USA
Founded
-
iTeos Therapeutics Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker ITOS. The last closing price for iTeos Therapeutics was $7.90. Over the last year, iTeos Therapeutics shares have traded in a share price range of $ 7.09 to $ 18.75.

iTeos Therapeutics currently has 36,533,918 shares outstanding. The market capitalization of iTeos Therapeutics is $288.62 million. iTeos Therapeutics has a price to earnings ratio (PE ratio) of -2.65.

ITOS Latest News

iTeos Therapeutics Presents Interim A2A-005 Clinical Trial Data, Translational, and Preclinical Data from Inupadenant at ESMO Immuno-Oncology Congress

- Inupadenant + carboplatin/pemetrexed in Phase 2 A2A-005 trial demonstrated a 63.9% overall response rate (ORR) and a median PFS of 7.7 months for all evaluable patients across the cohorts...

iTeos to Participate in Upcoming Investor Conferences

WATERTOWN, Mass. and GOSSELIES, Belgium, Nov. 26, 2024 (GLOBE NEWSWIRE) -- iTeos Therapeutics, Inc. (Nasdaq: ITOS), a clinical-stage biopharmaceutical company pioneering the discovery and...

iTeos Reports Third Quarter 2024 Financial Results and Provides Business Updates

- EMA granted clearance to advance belrestotug 400mg + dostarlimab as recommended Phase 3 dose and activate GALAXIES Lung-301 clinical sites in the EU- Interim data from inupadenant Phase 2...

iTeos Therapeutics to Highlight Inupadenant Preclinical, Translational, and Phase 2 A2A-005 Clinical Trial Data in 2L NSCLC at ESMO Immuno-Oncology Congress

WATERTOWN, Mass. and GOSSELIES, Belgium, Oct. 24, 2024 (GLOBE NEWSWIRE) -- iTeos Therapeutics, Inc. (Nasdaq: ITOS) (“iTeos”), a clinical-stage biopharmaceutical company pioneering the discovery...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.8211.18690313787.338.167.174695547.6011089CS
40.121.494396014948.038.577.095257217.62697581CS
12-0.92-10.14332965829.0710.217.095734358.4769151CS
26-6.44-44.139821795814.5918.137.0954006611.14029336CS
52-3.4-29.437229437211.5518.757.0944846312.13741441CS
156-43.75-84.296724470151.952.437.0941155617.65527674CS
260-11.55-58.629441624419.752.437.0936308420.32965149CS

ITOS - Frequently Asked Questions (FAQ)

What is the current iTeos Therapeutics share price?
The current share price of iTeos Therapeutics is $ 8.15
How many iTeos Therapeutics shares are in issue?
iTeos Therapeutics has 36,533,918 shares in issue
What is the market cap of iTeos Therapeutics?
The market capitalisation of iTeos Therapeutics is USD 288.62M
What is the 1 year trading range for iTeos Therapeutics share price?
iTeos Therapeutics has traded in the range of $ 7.09 to $ 18.75 during the past year
What is the PE ratio of iTeos Therapeutics?
The price to earnings ratio of iTeos Therapeutics is -2.65
What is the cash to sales ratio of iTeos Therapeutics?
The cash to sales ratio of iTeos Therapeutics is 23.67
What is the reporting currency for iTeos Therapeutics?
iTeos Therapeutics reports financial results in USD
What is the latest annual turnover for iTeos Therapeutics?
The latest annual turnover of iTeos Therapeutics is USD 12.6M
What is the latest annual profit for iTeos Therapeutics?
The latest annual profit of iTeos Therapeutics is USD -112.64M
What is the registered address of iTeos Therapeutics?
The registered address for iTeos Therapeutics is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the iTeos Therapeutics website address?
The website address for iTeos Therapeutics is www.iteostherapeutics.com
Which industry sector does iTeos Therapeutics operate in?
iTeos Therapeutics operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
FCUVFocus Universal Inc
$ 0.9499
(174.93%)
259.78M
NITON2OFF Inc
$ 2.6306
(145.85%)
350.92M
CRNCCerence Inc
$ 19.33
(143.76%)
159.55M
KITTNauticus Robotics Inc
$ 3.8249
(140.56%)
104.78M
ACONAclarion Inc
$ 0.2984
(110.14%)
305.59M
HWHHWH International Inc
$ 0.4621
(-28.80%)
7.43M
SMSTDefiance Daily Target 2x Short MSTR ETF
$ 5.69
(-26.30%)
24.77M
RAINRain Enhancement Technologies Holdco Inc
$ 5.59
(-23.42%)
161.15k
PTLEPTL Ltd
$ 9.35
(-23.30%)
1.04M
NXUNXU Inc
$ 0.725868
(-22.78%)
7.59M
NITON2OFF Inc
$ 2.6306
(145.85%)
350.92M
TGLTreasure Global Inc
$ 0.382
(101.58%)
330.82M
ACONAclarion Inc
$ 0.2984
(110.14%)
305.59M
FCUVFocus Universal Inc
$ 0.9499
(174.93%)
259.78M
NVDANVIDIA Corporation
$ 144.47
(4.45%)
222.72M

ITOS Financials

Financials
Rendering Error

ITOS Discussion

View Posts
Monksdream Monksdream 2 weeks ago
ITOS, under $8
👍️0
Monksdream Monksdream 2 months ago
ITOS under $10
👍️0
Monksdream Monksdream 4 months ago
ITOS needs to break $19
👍️0
Awl416 Awl416 8 months ago
iTeos Therapeutics Announces $120 Million Registered Direct Offering
👍️0
TonyJoe1957 TonyJoe1957 3 years ago
$14.41 EPS estimate for 3rd quarter posted today on TDAmeritrade.
👍️0
TonyJoe1957 TonyJoe1957 3 years ago
https://seekingalpha.com/article/4449555-iteos-therapeutics-my-calculations-suggest-q3-earnings-will-exceed-10-per-share
👍️0
TonyJoe1957 TonyJoe1957 3 years ago
Wow!
No one posting or interested in this stock?
👍️0
TonyJoe1957 TonyJoe1957 4 years ago
Note the intraday lows for the past 3 trading days. Program trading walking it down to $25.60, $25.30 and $25.25. Stay well. AJ
👍️0
TonyJoe1957 TonyJoe1957 4 years ago
I think we are trading below cash per share.
👍️0
ALERTS100%to10000%GAIN ALERTS100%to10000%GAIN 4 years ago
ITOS $28.50 gonna be wild in little after $30
👍️0
ALERTS100%to10000%GAIN ALERTS100%to10000%GAIN 4 years ago
Itos will break $30 and game on,holding here
👍️0
ALERTS100%to10000%GAIN ALERTS100%to10000%GAIN 4 years ago
ITOS~~$28.11
👍️0
ALERTS100%to10000%GAIN ALERTS100%to10000%GAIN 4 years ago
ITOS~~MA200,@ $28.75,should break today here
👍️0
TonyJoe1957 TonyJoe1957 4 years ago
Bought 580 sh, so far.
5 analysts at 8:30A webcast.
All congratulated the firm on the deal.
I anticipate an easy double in the next few months with upgrades.
Look at the balance sheet.
Really, really big cash infusion.
AJ
👍️0
ALERTS100%to10000%GAIN ALERTS100%to10000%GAIN 4 years ago
ITOS~~bought 809 shares @$33pm,little high on spike ,but should go nicely up,crazy huge news
👍️0
$treet $inatra $treet $inatra 4 years ago
https://investors.iteostherapeutics.com/news-and-events/press-releases


👍️0

Your Recent History

Delayed Upgrade Clock